John Paul Johnson - Feb 22, 2024 Form 4 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Financial Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Stock symbol
EVH
Transactions as of
Feb 22, 2024
Transactions value $
-$660,798
Form type
4
Date filed
2/26/2024, 04:43 PM
Previous filing
Mar 3, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVH Class A Common Stock Award $0 +44K +22% $0.00 244K Feb 22, 2024 Direct F1, F2
transaction EVH Class A Common Stock Tax liability -$661K -20K -8.2% $33.03 224K Feb 22, 2024 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023.
F2 Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
F3 This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units.